GlassScriptPhysician profile
Nicole M Bailey
NPI 1225678394
$3,630.65
in general payments reported to CMS, 2019-2025
16 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,679 · 2022: $1,212 · 2023: $440 · 2024: $163 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $735.70 | 2021 | |
| Nevro Corp. | $724.62 | 2021-2024 | Senza |
| Abbvie INC. | $559.26 | 2021-2023 | |
| Boston Scientific Corporation | $340.80 | 2021-2022 | |
| Abiomed | $245.31 | 2023 | Impella |
| Biohaven Pharmaceutical Holding Company LTD. | $178.43 | 2022 | |
| Allergan, INC. | $176.81 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $170.04 | 2021-2022 | |
| Globus Medical, INC. | $136.89 | 2025 | Vyrsa V1, Senza |
| Medtronic, INC. | $120.15 | 2021-2023 | Intellis Adaptivestim |
| Bioventus LLC | $66.03 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $42.47 | 2021 | |
| Uswm, LLC | $39.91 | 2021 | |
| Hikma Pharmaceuticals USA | $35.00 | 2022 | |
| Fidia Pharma USA INC. | $31.40 | 2021-2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $27.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.